Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
RESEARCH TOOLSreports
Holding RBOT?
Track your performance easily
RBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.27 - $19.00
Previous CloseN/A
Volume30.88K
Average Volume (3M)54.79K
Market Cap
$84.25M
Enterprise Value-$13.29M
Total Cash (Recent Filing)$173.51M
Total Debt (Recent Filing)$675.00K
Price to Earnings (P/E)―
Beta2.86
Next Earnings
Feb 27, 2025EPS Estimate
-2.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.66
Shares Outstanding5,254,229
10 Day Avg. Volume70,177
30 Day Avg. Volume54,794
Standard Deviation0.24
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.47
Forecast
1Y Price Target
$11.17Price Target Upside-29.53% Downside
Rating ConsensusHold
Number of Analyst Covering4
Vicarious Surgical News
PremiumCompany Announcements
Vicarious Surgical Announces CFO William Kelly’s Resignation
PremiumCompany Announcements
Vicarious Surgical Inc. Reports Q3 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Financial ManagementRBOT continues to manage its cash position responsibly, with cash management remaining a key priority ahead of key milestones for its robotic platform.
Market OutlookThe new price target of $13 reflects a positive outlook, increasing from the previous target of $10, based on future sales estimates and a discount rate.
Product DevelopmentThe final integration of the Version 1.0 System is just weeks away, which should allow the company to move towards testing and its first clinical patient experience.
Bears Say
Financial HealthRBOT exited with $60.9M in cash and will likely need additional capital to bring its system to market.
Leadership ChangesThe CFO departure is seen as another challenge for RBOT to handle on its path towards gaining clearance.
Product DevelopmentThe pathway to approval for RBOT has been challenging with timelines projected out to late FY26 and into FY27 before commercial launch.
---
Options Prices
Currently, No data available
---
Ownership Overview
48.83% Insiders
3.70% Mutual Funds
<0.01% Other Institutional Investors
44.66% Public Companies and Individual Investors
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $4.27 and its highest was $19.00 in the past 12 months.
What is Vicarious Surgical’s market cap?
Vicarious Surgical’s market cap is $84.25M.
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is Feb 27, 2025 which is in 39 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Nov 12, 2024. The company reported -$2.877 earnings per share for the quarter, missing the consensus estimate of -$2.575 by -$0.302.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -2.69.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,254,229 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.877 in its last earnings report, missing expectations of -$2.575. Following the earnings report the stock price went down -17.864%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Currently, no hedge funds are holding shares in RBOT
---
Vicarious Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.17 (-29.53% Downside)
$11.17 (-29.53% Downside)
Insider Transactions
Sold Shares
Worth $32.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.28%
12-Months-Change
Fundamentals
Return on Equity
-75.30%
Trailing 12-Months
Asset Growth
-38.95%
Trailing 12-Months
Company Description
Vicarious Surgical
D8 Holdings Corp is a blank check company.
---
RBOT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call was largely focused on the positive strides made in reducing operational costs, advancing the single-port platform, and maintaining a strong financial position. However, significant challenges remain, including the need to achieve regulatory approval and address ongoing net losses.Read More>---
RBOT Stock 12 Month Forecast
Average Price Target
$11.17
▼(-29.53% Downside)
Technical Analysis
Intuitive Surgical
―
InMode
―
Outset Medical
―
Globus Medical
―
HCA Healthcare
―
Thermo Fisher
―
Best Analysts Covering RBOT
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+43.90%
assigned a buy rating 2 months ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +43.90% per trade.
---